A common variant on chromosome 4q25 is associated with prolonged PR interval in subjects with and without atrial fibrillation.

[1]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[2]  K. Lunetta,et al.  Meta-analysis identifies six new susceptibility loci for atrial fibrillation , 2012, Nature Genetics.

[3]  J. Elmquist,et al.  Genetic tracing of Nav1.8‐expressing vagal afferents in the mouse , 2011, The Journal of comparative neurology.

[4]  K. J. Herron,et al.  Uncovering an intermediate phenotype associated with rs2200733 at 4q25 in lone atrial fibrillation. , 2011, The American journal of cardiology.

[5]  Leif Hove-Madsen,et al.  PITX2 Insufficiency Leads to Atrial Electrical and Structural Remodeling Linked to Arrhythmogenesis , 2011, Circulation. Cardiovascular genetics.

[6]  Ulrich Schotten,et al.  PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression , 2011, Circulation. Cardiovascular genetics.

[7]  Randy L. Johnson,et al.  Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification , 2010, Proceedings of the National Academy of Sciences.

[8]  Melissa A. Basford,et al.  Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. , 2010, American journal of human genetics.

[9]  D. Levy,et al.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.

[10]  D. Levy,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[11]  D. Roden,et al.  Development of a Large‐Scale De‐Identified DNA Biobank to Enable Personalized Medicine , 2008, Clinical pharmacology and therapeutics.

[12]  Richard P Harvey,et al.  Pitx2c and Nkx2-5 Are Required for the Formation and Identity of the Pulmonary Myocardium , 2007, Circulation research.

[13]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[14]  D. Roden,et al.  Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. , 2007, Heart rhythm.

[15]  J. Ornato,et al.  [ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[16]  Richard P. Harvey,et al.  Molecular Pathway for the Localized Formation of the Sinoatrial Node , 2007, Circulation research.

[17]  J. Ornato,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit , 2006, Journal of the American College of Cardiology.

[18]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[19]  V. Santinelli,et al.  Prevention of Atrial Fibrillation: , 2004, Journal of cardiovascular electrophysiology.

[20]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[21]  M. Gold,et al.  Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block , 2010 .